A recombinant plasmid was constructed by ligation of chromosomal DNA from a sulfanilamide-resistant strain of Bacillus subtilis to the plasmid vector pUB110 which specifies neomycin resistance. Recombinant molecules generated in vitro were introduced into a B. subtilis recipient strain which carried the recE4 mutation, and selection was for neomycin-sulfanilamide-resistant transformants. A single colony was isolated containing the recombinant plasmid pKO101. This 6.3-megadalton plasmid simultaneously conferred resistance to neomycin and sulfanilamide when transferred into sensitive Rec+ or Rec-cells by either transduction or transformation.
A recombinant plasmid was constructed by ligation of chromosomal DNA from a sulfanilamide-resistant strain of Bacillus subtilis to the plasmid vector pUB110 which specifies neomycin resistance. Recombinant molecules generated in vitro were introduced into a B. subtilis recipient strain which carried the recE4 mutation, and selection was for neomycin-sulfanilamide-resistant transformants. A single colony was isolated containing the recombinant plasmid pKO101. This 6.3-megadalton plasmid simultaneously conferred resistance to neomycin and sulfanilamide when transferred into sensitive Rec+ or Rec-cells by either transduction or transformation.
Bacillus subtilis has emerged as a major organism for exploration of genetics, physiology, and industrial applications of bacilli. Development of a molecular cloning system in B. subtilis promises to further expand the usefulness of this organism.
For examination of the utility of this system for cloning specific regions of the B. subtilis chromosome, a well-mapped and easily selected chromosomal gene, sul, was inserted into a Staphylococcus aureus plasmid vector. The sul gene specifies chromosomally determined sulfanilamide resistance in B. subtilis. In Escherichia coli, this antibiotic resistance is thought to be the result of a chromosomal mutation which gives rise to an altered form of the sulfanilamide target enzyme, dihydropteroic acid synthetase. This form is much less sensitive to sulfanilamide but retains a normal affinity for the natural substrate, p-aminobenzoic acid (8) . The exact mechanism of sulfanilamide resistance in B. subtilis has not been determined.
This report describes the construction, selection, and characterization of a recombinant plasmid carrying the B. subtilis sul gene.
All strains used in these experiments were B. subtilis 168 derivatives. B. subtilis ASB327 was used as the transformable recipient. Chromosomal DNA was isolated from the sulfanilamideresistant strain VB157. These and other strains used are listed in Table 1 .
Chromosomal DNA was isolated from strain VB157, using the technique previously described by Burke and Spizizen (3) .
The cloning vector pUB110 is a 3.0-megadalton (Mdal) plasmid coding for resistance to neomycin and was isolated from B. subtilis as described by Gryczan et al. (6) with the following exception. After the sodium dodecyl sulfatesalt precipitation step, the supematant was carefully decanted, warmed at 37°C, and incubated with 20 ,ug of proteinase K per ml in a water bath shaker at 37°C and 150 rpm. The DNA was then ethanol precipitated and purified as previously described (6) .
Restriction endonucleases BamHI, BglII, HindIII, and HpaII were obtained from New England Biolabs, as was T4 DNA ligase. EcoRI was purchased from Sigma Chemical Co.
With the exception ofEcoRI, restriction endonuclease cleavage was performed with a modification of digestion buffers described previously (6) . The modification involved the omission of bovine serum albumin from the buffers. EcoRI cleavage was performed using a buffer consisting of 100 mM Tris-hydrochloride (pH 7.5), 5 mM MgCl2, and 50 mM NaCl. In all cases, restriction endonuclease cleavage was accomplished using 1 to 2 U of restriction endonuclease per ,ug of DNA and incubating the mixture at 37°C for 2 to 3 h. The reaction was terminated by heating at 65°C for 10 min. The ratio of EcoRIdigested pUB110 plasmid DNA to EcoRI-digested VB157 chromosomal DNA in the ligation mixture was 1:10. Ligation of DNA was performed with T4 ligase; the ligation mixture consisted of 50 I,M ATP, 7.5 mM MgCl2, 10 mM Tris-hydrochloride (pH 7.5), and 30 Fg of EcoRI-digested DNA in a total volume of 200 ,u. The mixture was incubated for 15 h at 4°C before the addition of 200 U of ligase and further incubation at 4°C for 24 h.
Transformations were performed as described previously (1), using a final DNA concentration of 5 ,ug/ml. Transformants were selected on minimal plates containing 1,500 ,ug of sulfanilamide per ml.
The procedure for the transduction experi (2) .
Agarose gels, varying in concentration from 0.8 to 1.5%, were used to resolve plasmid and chromosomal DNAs. The Tris-borate buffer of Greene et al. (5) was used throughout. Vertical gels were performed at a constant voltage of 80 V for 4 h. Horizontal gels were prepared and run as described by Davis et al. (4) . Gels were stained in ethidium bromide (1 ,g/ml) for 30 min at room temperature and photographed using shortwave UV light with Polaroid type 57 film and a Kodak 23A red filter. The molecular weight of the recombinant plasmid pKO101 was determined using HindIII and HindIII-EcoRI fragments as standards (11) .
EcoRI-digested pKO101 plasmid DNA was separated electrophoretically on an 0.8% agarose gel, and fragments were recovered from gel slices by electrophoretic elution as described by Southern (11) . The ethidium bromide in the DNA samples was removed by dialysis, and these fragments of plasmid DNA were used in subsequent transformations.
Minimal inhibitory concentrations (MICs) of sulfanilamide, sulfathiazole, and sulfamerazine were determined by replica plating to minimal plates containing antibiotic. Strains to be tested were transferred to a tryptose blood agar base plate with 0.5% glucose and 50 ;.g of thymine per ml. After 3 h of incubation at 37°C, this plate was used as a master plate for replication to minimal plates containing various concentrations of the appropriate antibiotic in addition to the auxotrophic requirements of the strains. These plates were incubated at 37C and scored for growth at 24, 48, and 72 h.
A single neomycin-sulfanilamide-resistant clone was isolated when 5 pg of a ligated mixture of EcoRI-digested pUB110 and VB157 chromosomal DNAs was used to transform competent cells of the Rec-B. subtilis ASB327.
Examination of a cleared lysate of the transformant by agarose gel electrophoresis revealed that the host had acquired a plasmid with a larger molecular weight than that of the vector plasmid pUBI1O. The recombinant plasmid was designated pKO101.
PBS1 was propagated on ASB338 carrying the recombinant plasmid pKO101 and used to transduce the recE4 strain BD224. Selection for transductants that were resistant to both neomycin and sulfanilamide at concentrations of 5 and 1,500 ,g/ml, respectively, resulted in 1.1 x lo transductants per ml.
Competent BD224 cells were transformed with pKO101, and transformants were selected with either neomycin at a final concentration of 5 ,ug/ml or sulfanilamide at a final concentration of 1,500 tLg/ml. Selection with neomycin resulted in a transformation frequency of 0.43%, and selection with sulfanilamide resulted in a transformation frequency of 0.62%. Transformants selected with neomycin were replica plated to sulfanilamide selective medium, and colonies selected with sulfanilamide were replica plated to neomycin selective medium. All of the transformants selected for sulfanilamide resistance were also neomycin resistant, whereas approximately 80% of the transformants selected for neomycin resistance were also sulfanilamide resistant.
For an estimation of the stability of pKO101 in recE4 B. subtilis, the plasmid-bearing strain was grown at 37°C for 3 h in MM2 medium (2x Penassay broth plus 0.5% yeast extract). The culture was diluted and plated on tryptose blood agar base medium and incubated at 30°C overnight. Colonies were then transferred to tryptose blood agar base, incubated at 37°C for 3 h, and replica plated to minimal plates containing either 1,500 ,ug of sulfanilamide per ml, 5 ,ug of neomycin per ml, or both. Of 860 colonies examined, approximately 40%o (338) were found to be sensitive to both antibiotics. This is especially noteworthy when compared with the extreme stability of the vector plasmid pUB110 (6) . No loss of either of the resistance characters of pKO101 was detected when sulfanilamide selection alone was maintained.
Purified hybrid plasmid was digested with a number of restriction endonucleases and found to have single cleavage sites for endonucleases BamHI (Fig. 1, lane D -nts (Fig. 1, lane B fragment. These results resistance to sulfanilamide was expressed in the fanilamide resistance was recE4 recipient in both transduction and transXd with the A fragment. formation experiments strongly suggests that the ested pUB110 ligated to sul gene is located on the recombinant extrale to transform recombina-chromosomal element. Spontaneous loss of the cells to the sulfanilamide-sulfanilamide phenotype occurred in approximately 40% of the recombinant cells when selecnilamide was determined tion for the sul gene was not maintained, also the presence and absence indicating that this characteristic is located exasmid ( Table 2 ). The MIC trachromosomally. ncreased by over threefold
The cloned 3.3-Mdal chromosomal DNA )101. The presence of the probably was generated by incomplete EcoRI 10 in cells did not affect digestion of VB157 DNA. The region of the ilfanilamide. Further, the cloned DNA essential for the sulfanilamideecombinant plasmid were resistant phenotype appears to be associated a of resistance to sulfamer-with the A fragment, since this fragment was ml) and sulfathiazole (MIC capable of transforming Rec+ competent The level of resistance to sulfanilamide was greater for the strains harboring the recombinant plasmid pKO101 (ASB338, ASB341, and ASB342) than for the sulfanilamide-resistant VB157 which was the source of the cloned sul gene (Table 2) . This may be due to the presence of multiple copies of the recombinant plasmid, ndonuclease analyses of vari-although this gene dosage effect has not been agarose gel electrophoresis. experimentally confirmed. The inclusion of neoseparated on a 1.5% gel at 80 mycin in the media did not alter the MIC for the 
